The only retrospective human study included 12 patients who received intra-articular BPC-157 for chronic knee pain, of whom 7 reported symptom improvement lasting more than 6 months
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
Some of the symptoms include: Constant tiredness Weakness Brain fog Tingling in the feet or hands Anxiety or moodiness Pale skin Poor memory If you experience any of these symptoms and youre concerned, speaking to a Private Medical in West Ealing is the best way to get a better understanding of your health condition and determine if you have a B12 deficiency
Because this treatment is safe for everyone, it does not have any side effects risks or medical restrictions
If you are looking for a peptide dosage calculator for another peptide we have you covered
EMA Decision P/0336/2024 Paediatric Investigation Plan for Retatrutide